INTELLIGENCE IN ACTION

Now Trending: EPCS Among Physicians and Medicare Part D Patients

October 22, 2019

As we approach the one-year anniversary of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act, I am optimistic about the direction of a key provision outlined in the legislation, that is, the use of electronic prescribing of controlled substance (EPCS) among Medicare Part D providers. Congress passed the SUPPORT Act in October 2018 to address the opioid epidemic, and within the law the SUPPORT Act requires that all Medicare Part D covered controlled substance prescriptions must be transmitted electronically by 2021. Although utilization of EPCS among Medicare Part D prescribers is on the rise, there is still room for growth in order to implement the new law by 2021.

In an effort to help drive adoption of EPCS,  I recently worked with researchers at the Office of the National Coordinator for Health Information Technology (ONC) on a data brief, Electronic Prescribing of Controlled Substances among Medicare Part D Prescribers 2015-2016.

In a nutshell, we studied the landscape of Medicare Part D prescribers’ use of EPCS between 2015 and 2016 by prescriber specialty, prescriber state, and by Part D opioid claim volume.

According to the data brief, pain management specialists had the largest proportion of EPCS utilizers, among Medicare Part D Prescribers, that is, 21% of these specialists transmitted their controlled substance prescriptions, electronically.

Between 2015 and 2016 the proportion of all Medicare Part D prescribers who used EPCS increased from 4% to 11% and Medicare Part D opioid prescribers using EPCS more than doubled, from 5% in 2015 to 13% in 2016. While we still have a long way to go, we’re making progress. For reference, EPCS enablement among all prescribers (not just Medicate Part D) has climbed to more than 41% as of September 2019.

The work that went into this data brief —and the results it generated—also help us to understand which prescribers are using EPCS and the areas of the country where it’s being utilized. Additionally, it provides the analytical framework to anticipate continued growth in EPCS among Medicare Part D prescribers, and follow that trend to 2021 and beyond. It’s worth noting that our findings were consistent with the EPCS state rankings outlined in Surescripts’ 2016 National Progress Report, where New York State led the way in EPCS adoption and utilization, followed by North Dakota, and South Dakota; all states with a higher proportion of Medicare Part D prescribers.

The opioid crisis has devastated countless communities across the country, and this technology can impact patients, heal families and start to rebuild those communities. We must continue working together across the industry and with government in order to impact provider behavior in a way that helps fight the epidemic.

Read ONC’s blog post for more insight into the data report findings.

Related Articles

September 15, 2020

The Opioid Crisis Is Still with Us

Mental health experts and the recovery community have been sounding the alarm for months now. But there are things that the healthcare industry is doing—and can continue to embrace—that are of real help in combatting the crisis. 

Read more...
July 16, 2020

Revisiting a Groundbreaking Prescribing Regulation

More than a decade ago, the U.S. Drug Enforcement Administration (DEA) published its Electronic Prescribing for Controlled Substances (EPCS) Interim Final Rule (IFR). Surescripts applauded this regulation, which took effect on June 1, 2010. 

Read more...
March 31, 2020

Five Questions: Ken Whittemore Talks Past, Present & Future of E-Prescribing Controlled Substances

In the early 2000s, as the nation moved towards e-prescribing, Ken Whittemore Jr. was one of the key drivers and proponents of this new technology. By 2007, as a result of the efforts of Surescripts and other stakeholders, e-prescribing had become legal in all 50 states. Three years later, the regulatory climate was ready for the next leap in e-prescribing: in March 2010, the U.S. Drug Enforcement Administration (DEA) issued an Interim Final Rule (IFR) allowing for the electronic prescribing of controlled substances (EPCS) across the nation.  Read more...

INTELLIGENCE IN ACTION, DELIVERED TO YOUR INBOX